Skip to main content
. Author manuscript; available in PMC: 2016 Apr 11.
Published in final edited form as: J Mol Cell Cardiol. 2015 Jan 7;80:114–125. doi: 10.1016/j.yjmcc.2014.12.021

Figure 6. Effect of pharmacological inhibition of PI3K IA by PI-103 on OPC and IPC-induced myocardial protections.

Figure 6

PI-103 100 nM was co-administered with OPC or IPC treatment prior to ischemia (figure 1). Left ventricular developed pressure (LVDP, 6A), basal and final end diastolic pressures (EDP, 6B) and lactate dehydrogenase release (LDH, 6C) are shown. Values are mean ± SEM (n=5). *** P<0.001 vs. OPC.